Mills Kenneth T. — SEC Form 4 filings
SEC reporting owner CIK 1652824. 13 Form 4 filings on record with FilingPulse; latest filed 2026-06-02.
Transaction summary — filings shown
Covers all 13 filings on record, filed 2024-01-18 to 2026-06-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 11 legs across 8 filings — 155,602 shares, $2,351,548 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 31.
- Largest priced transaction: sale of 45,000 shares @ $15.18 ($682,992) in REGENXBIO Inc., filed 2024-01-18.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| REGENXBIO Inc. (RGNX) | Director | 13 | — | 11 legs · 155,602 sh · $2,351,548 | 31 |
Form 4 filings — Mills Kenneth T.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-02 | 4 | REGENXBIO Inc. (RGNX) | Grant/award (A): 9,807 @ $0 · Grant/award (A): 46,600 (derivative) @ $0 | EDGAR |
| 2026-01-29 | 4 | REGENXBIO Inc. (RGNX) | Option exercise (M): 225,000 @ $13.09 · Tax withholding (F): 221,753 @ $13.41 · Option exercise (M): 225,000 (derivative) @ $0 | EDGAR |
| 2025-06-03 | 4 | REGENXBIO Inc. (RGNX) | Grant/award (A): 7,768 @ $0 · Grant/award (A): 39,815 (derivative) @ $0 | EDGAR |
| 2025-05-14 | 4 | REGENXBIO Inc. (RGNX) | Option exercise (M): 20,602 @ $3.76 · Sale (S): 20,602 @ $7.91 · Option exercise (M): 20,602 (derivative) @ $0 | EDGAR |
| 2025-03-31 | 4 | REGENXBIO Inc. (RGNX) | Option exercise (M): 30,752 @ $3.76 · Option exercise (M): 30,752 (derivative) @ $0 | EDGAR |
| 2024-08-12 | 4 | REGENXBIO Inc. (RGNX) | Option exercise (M): 36,316 @ $0.85 · Option exercise (M): 36,316 (derivative) @ $0 | EDGAR |
| 2024-07-26 | 4 | REGENXBIO Inc. (RGNX) | Option exercise (M): 12,221 @ $3.76 · Sale (S): 12,221 @ $13.78 · Option exercise (M): 15,369 @ $3.76 · Sale (S): 15,369 @ $13.96 · Option exercise (M): 12,221 (derivative) @ $0 · Option exercise (M): 15,369 (derivative) @ $0 | EDGAR |
| 2024-07-18 | 4 | REGENXBIO Inc. (RGNX) | Option exercise (M): 200 @ $3.76 · Sale (S): 200 @ $13.76 · Option exercise (M): 2,210 @ $3.76 · Sale (S): 2,210 @ $13.77 · Option exercise (M): 200 (derivative) @ $0 · Option exercise (M): 2,210 (derivative) @ $0 | EDGAR |
| 2024-05-16 | 4 | REGENXBIO Inc. (RGNX) | Option exercise (M): 15,000 @ $3.76 · Sale (S): 15,000 @ $15.81 · Option exercise (M): 15,000 (derivative) @ $0 | EDGAR |
| 2024-04-17 | 4 | REGENXBIO Inc. (RGNX) | Option exercise (M): 15,000 @ $3.76 · Sale (S): 15,000 @ $18.19 · Option exercise (M): 15,000 (derivative) @ $0 | EDGAR |
| 2024-03-18 | 4 | REGENXBIO Inc. (RGNX) | Option exercise (M): 15,000 @ $3.76 · Sale (S): 15,000 @ $21.86 · Option exercise (M): 15,000 (derivative) @ $0 | EDGAR |
| 2024-02-16 | 4 | REGENXBIO Inc. (RGNX) | Option exercise (M): 15,000 @ $3.76 · Sale (S): 4,652 @ $16.47 · Sale (S): 10,348 @ $16.88 · Option exercise (M): 15,000 (derivative) @ $0 | EDGAR |
| 2024-01-18 | 4 | REGENXBIO Inc. (RGNX) | Option exercise (M): 45,000 @ $3.76 · Sale (S): 45,000 @ $15.18 · Option exercise (M): 45,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1652824 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →